Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

M. Brand

39 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: https://openalex.org/A5051417409

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Receptor Pharmacology 15 Depression 14 Clinical Trial 10 Mechanism of Action 9 Animal Study 8 Treatment-Resistant Depression 6 Safety 5 Neuroplasticity 5 Anxiety 5 Pharmacology 5 Addiction 4 Consciousness 4

Journals

Journal of psychopharmacology (Oxford, England) 3 Molecular psychiatry 2 Neuroscience Applied 2 Progress in neuro-psychopharmacology & biological psychiatry 2 Psychological medicine 2 Neuropharmacology 2 The Chemical Educator 2 Cell Reports Medicine 1

Publication history

Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.Molecular psychiatry · 2026-07-28 Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-07-01 Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic ActionCurrent Psychiatry Reports · 2026-06-05 Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-27 High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats.Journal of psychopharmacology (Oxford, England) · 2026-05-01 Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-05-01 Delayed psilocybin treatment after repeated mild traumatic brain injury recovers chronic behavioural deficits, reduces microglial density, and enhances hippocampal neurogenesis in ratsResearch Square · 2026-02-23 Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers.Research square · 2026-02-12 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trialNeuroscience Applied · 2026-01-01 Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02 Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.Progress in neuro-psychopharmacology & biological psychiatry · 2025-08-30 Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing StudyPsyArXiv · 2025-03-07 A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01 An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers.Neuroscience applied · 2025-01-01 Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.JAMA network open · 2024-12-02 Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.Current psychiatry reports · 2024-11-01 Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.EClinicalMedicine · 2024-10-01 Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.Psychological medicine · 2024-06-01 Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive DisorderInternational Journal of Mental Health and Addiction · 2024-03-07 Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2024-01-01 Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.Psychological medicine · 2024-01-01 Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats.Molecular psychiatry · 2023-09-01 A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.Journal of psychopharmacology (Oxford, England) · 2023-07-01 Canalization and plasticity in psychopathology.Neuropharmacology · 2023-03-15 A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illnessDrug Science Policy and Law · 2023-01-01 Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17 Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.Drug testing and analysis · 2022-08-01 [Are psychedelics fast acting antidepressant agents?].Der Nervenarzt · 2022-03-01 Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.International journal of molecular sciences · 2021-11-30 Investigation of the Structure-Activity Relationships of Psilocybin Analogues.ACS pharmacology & translational science · 2021-04-09 Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.Neuropharmacology · 2020-05-01 Horizontal gene cluster transfer increased hallucinogenic mushroom diversity.Evolution letters · 2018-04-01 Mushroom poisoning epidemiology in the United States.Mycologia · 2018-01-01 Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi.PloS one · 2013-01-01 Salvia divinorum use and phenomenology: results from an online survey.Journal of psychopharmacology (Oxford, England) · 2011-11-01 Detection of Psilocybin Mushroom Analogs in ChocolateThe Chemical Educator · 2009-12-01 Detection of Psilocybin Mushroom Analogs in Chocolate: Incorporating Current Events into the Undergraduate Teaching LaboratoryThe Chemical Educator · 2009-01-01 HallucinogensPediatrics in Review · 2006-08-01 Polymorphe Modifikationen und Solvate von Psilocin und PsilocybinArchiv der Pharmazie · 1976-01-01

Author directory